Immunoconjugate for human CD66 for the treatment of multiple myeloma and other haematological malignancies
US9072797B2 · kind B2 · utility
0Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 2006 |
| Grant date | Jul 7, 2015 |
| Priority date | — |
| Expiry date | Jun 2, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of radioimmunoconjugates for the treatment of haematological malignancies, particularly multiple myeloma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.